Interaction of radiation and smoking in lung cancer induction among workers at the Mayak nuclear enterprise.

Southern Ural Biophysics Institute, Ozyorsk, Russia.
Health Physics (Impact Factor: 0.77). 12/2002; 83(6):833-46. DOI: 10.1097/00004032-200212000-00011
Source: PubMed

ABSTRACT For radiation-related cancer risk evaluation, it is important to assess not only influences of individual risk factors but also their interactive effects (e.g., additive, multiplicative, etc.). Multivariate analysis methods adapted for interactive effects allow such assessments. We have used a multivariate analysis approach to investigate the pair-wise interactions of the previously identified three main etiological factors for lung cancer induction in Russian workers of the Mayak Production Association (PA) nuclear enterprise. These three factors are as follows: (1) body burden of inhaled plutonium-239 (239Pu), an influence on absorbed alpha-radiation dose; (2) cumulative, absorbed external gamma-radiation dose to the lung; and (3) level of cigarette smoking as indicated by a smoking index (SI). The SI represents the cigarettes smoked per day times years smoking. The Mayak PA workers were exposed by inhalation to both soluble and insoluble forms of 239Pu. Based on a cohort of 4,390 persons (77% male), we conducted a nested, case-control study of lung cancer induction using 486 matched cases and controls. Each case was matched to two controls. Matching was based on five factors: sex, year of birth, year work began, profession, and workplace. Three levels of smoking were considered: low (SI = 1 to 499), used as a reference level; middle (SI = 500 to 900); and high (SI = 901 to 2,000). For lung cancer induction, a supra-multiplicative effect was demonstrated for high external gamma-ray doses (> 2.0 Gy) plus high 239Pu intakes (body burden >2.3 kBq). This observation is consistent with the hypothesis of curvilinear dose-response relationships for lung cancer induction by high- and low-LET radiations. The interaction between radiation (external gamma rays or 239Pu body burden) and cigarette smoke was found to depend on the smoking level. For the middle level of smoking in combination with gamma radiation (> 2.0 Gy) or 239Pu body burden (> 2.3 kBq), results were consistent with additive effects. However, for the high level of smoking in combination with gamma radiation (> 2.0 Gy) or 239Pu body burden (> 2.3 kBq), results were consistent with the occurrence of multiplicative effects. These results indicate that low-dose risk estimates for radiation-induced lung cancer derived without adjusting for the influence of cigarette smoking could be greatly overestimated. Further, such systematic error may considerably distort the shape of the risk vs. dose curve and could possibly obscure the presence of a dose threshold for radiation-induced lung cancer.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Lung cancer remains the leading cause of cancer-related death in the United States. Cigarette smoking is a well-recognized risk factor for lung cancer, and a sustained elevation of lung cancer risk persists even after smoking cessation. Despite identifiable risk factors, there has been minimal improvement in mortality for patients with lung cancer primarily stemming from diagnosis at a late stage when there are few effective therapeutic options. Early detection of lung cancer and effective screening of high-risk individuals may help improve lung cancer mortality. While low dose computerized tomography (LDCT) screening of high risk smokers has been shown to reduce lung cancer mortality, the high rates of false positives and potential for over-diagnosis have raised questions on how to best implement lung cancer screening. The rapidly evolving field of lung cancer screening and early-detection biomarkers may ultimately improve the ability to diagnose lung cancer in its early stages, identify smokers at highest-risk for this disease, and target chemoprevention strategies. This review aims to provide an overview of the opportunities and challenges related to lung cancer screening, the field of biomarker development for early lung cancer detection, and the future of lung cancer chemoprevention.
    06/2014; 6(2):1157-79. DOI:10.3390/cancers6021157
  • [Show abstract] [Hide abstract]
    ABSTRACT: Computed tomographic scan as a screening procedures in asymptomatic individuals has seen a steady increase with the introduction of multiple-raw detector CT scanners. This report provides a brief review of the current controversy surrounding CT cancer screening, with a focus on the radiation induced cancer risks and clinical efficacy. 1. A large study of patients at high risk of lung cancer(the National Lung Screening Trial[NLST]) showed that CT screening reduced cancer deaths by 20%(1.33% in those screened compared with 1.67% in those not screened). The rate of positive screening tests was 24.2% and 96.4% of the positive screening results in the low-dose CT group were false-positive. Radiation induced lung cancer risk was estimated the most important in screening population because ERR of radiation induced lung cancer does not show the decrease with increasing age and synergistic connection between smoking and radiation risk. Therefore, the radiation risk may be on the same order of magnitude as the benefit observed in the NLST. Optimal screening strategy remain uncertain, CT lung cancer screening is not yet ready for implementation. 2. Computed tomographic colonography is as good as colonoscopy for detecting colon cancer and is almost as good as colonoscopy for detecting advanced adenomas, but significantly less sensitive and specific for smaller lesions and disadvantageous for subsequent therapeutic optical colonoscopy if polyps are detected. The average effective dose from CT colonography was estimated 8-10 , which could be a significant dose if administered routinely within the population over many years. CT colonography should a) achieve at least 90% sensitivity and specificity in the size category from 6 and 10 mm, b) offer non-cathartic bowl preparation and c) be optimized and standardized CT parameters if it is to be used for mass screening. 3. There is little evidence that demonstrates, for whole-body scanning, the benefit outweighs the detriment. This test found large portion of patient(86~90.8%) had at least one abnormal finding, whereas only 2% were estimated to have clinically significant disease. Annual scans from ages 45 to 75 years would accrue an estimated lifetime cancer mortality risk of 1.9%. There is no group within the medical community that recommends whole-body CT. No good studies indicate the accuracy of screening CT, at this time. The benefit/risk balance for any of the commonly suggested CT screening techniques has yet to be established. These areas need further research. Therefore wild screening should be avoided.
    12/2013; 38(4). DOI:10.14407/jrp.2013.38.4.214
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Life on earth evolved in a low-level ionizing radiation environment comprised of terrestrial, solar, and cosmic radiations. A beneficial evolutionary consequence of the interaction of environmental low-level, sparsely ionizing radiations (e.g., X-rays, gamma rays, and beta particles) with mammalian organisms on earth is the suppression of genomic instability via radiation-hormesis-associated protective biological processes. Radiation hormesis as used here involves low-dose-induced protection from biological harm (e.g., cancer) that would otherwise occur spontaneously. High doses inhibit protection. This chapter focuses on the control of genomic instability and associated stochastic biological effects (e.g., mutant and neoplastically transformed cells and cancer) in mammals via radiation-hormesis-associated protective processes (adapted protection). Cancer risk increases as the numbers of mutant and neoplastically transformed (precancerous) cells increase. Mutant and neoplastically transformed cells increase as the number of cells with genomic instability increases. Thus, protective biological processes that suppress genomic instability also suppress mutant and neoplastically transformed cells and, thereby, prevent some spontaneous and environmental stressor-associated cancers that otherwise would have occurred. This chapter describes how a system of cooperative protective biological processes that are activated (or stimulated) by low doses of sparsely ionizing radiation likely suppress genomic-instability-associated diseases. The protective processes that make up this adapted protection include normal high-fidelity DNA repair/apoptosis (presumed to be p53-dependent), an auxiliary apoptosis process (presumably p53-independent) that selectively removes cells with genomic instability including mutant and neoplastically transformed cells, and the immune system. The auxiliary apoptotic component relates to what is called the protective apoptosis-mediated (PAM) process, which is considered to involve reactive oxygen and nitrogen species and specific cytokines (e.g., transforming growth factor ╬▓1). When activated by a low dose of sparsely ionizing radiation, the PAM process removes genomically unstable cells from our bodies and, along with activation of the immune system, can prevent some later occurring spontaneous cancers and other genomic-instability-associated diseases. Natural background sparsely ionizing radiation above a threshold dose activates the PAM process. The indicated hormesis-associated protective system and its activation by natural background radiation therefore guards against genomic instability and its adverse consequences to humans and other mammals. Reducing background radiation sources to the extent that radiation doses remain below the protective threshold will likely harm us rather than provide a benefit! Reduced life expectancy and significant increases in all genomic-instability-associated diseases would be the expected consequence of reducing background radiation to the degree indicated.